1
|
Mossialos E, Outterson K, Davies S, Anderson M. The antimicrobial resistance cube: a framework for identifying policy gaps and driving action. Lancet 2025:S0140-6736(25)00674-9. [PMID: 40318688 DOI: 10.1016/s0140-6736(25)00674-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/05/2025] [Accepted: 04/01/2025] [Indexed: 05/07/2025]
Affiliation(s)
- Elias Mossialos
- LSE Health, Department of Health Policy, London School of Economics and Political Science, London WC2A 2AE, UK.
| | | | - Sally Davies
- Trinity College, University of Cambridge, Cambridge, UK
| | - Michael Anderson
- LSE Health, Department of Health Policy, London School of Economics and Political Science, London WC2A 2AE, UK; Health Organisation, Policy, Economics (HOPE), Centre for Primary Care and Health Services Research, The University of Manchester, Manchester, UK
| |
Collapse
|
2
|
Napit R, Gurung A, Poudel A, Chaudhary A, Manandhar P, Sharma AN, Raut S, Pradhan SM, Joshi J, Poyet M, Groussin M, Rajbhandari RM, Karmacharya DB. Metagenomic analysis of human, animal, and environmental samples identifies potential emerging pathogens, profiles antibiotic resistance genes, and reveals horizontal gene transfer dynamics. Sci Rep 2025; 15:12156. [PMID: 40204742 PMCID: PMC11982193 DOI: 10.1038/s41598-025-90777-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2024] [Accepted: 02/17/2025] [Indexed: 04/11/2025] Open
Abstract
Antimicrobial resistance (AMR) poses a significant threat to global health. The indiscriminate use of antibiotics has accelerated the emergence and spread of drug-resistant bacteria, compromising our ability to treat infectious diseases. A One Health approach is essential to address this urgent issue, recognizing the interconnectedness of human, animal, and environmental health. This study investigated the prevalence and transmission of AMR in a temporary settlement in Kathmandu, Nepal. By employing shotgun metagenomics, we analyzed a diverse range of samples, including human fecal samples, avian fecal samples, and environmental samples. Our analysis revealed a complex interplay of pathogenic bacteria, virulence factors (VF), and antimicrobial resistance genes (ARGs) across these different domains. We identified a diverse range of bacterial species, including potential pathogens, in both human and animal samples. Notably, Prevotella spp. was the dominant gut bacterium in human samples. Additionally, we detected a wide range of phages and viruses, including Stx-2 converting phages, which can contribute to the virulence of Shiga toxin-producing E. coli (STEC) strains. Our analysis revealed the presence of 72 virulence factor genes and 53 ARG subtypes across the studied samples. Poultry samples exhibited the highest number of ARG subtypes, suggesting that the intensive use of antibiotics in poultry production may contribute to the dissemination of AMR. Furthermore, we observed frequent horizontal gene transfer (HGT) events, with gut microbiomes serving as key reservoirs for ARGs. This study underscores the critical role of a One Health approach in addressing AMR. By integrating human, animal, and environmental health perspectives, we can better understand the complex dynamics of AMR and develop effective strategies for prevention and control. Our findings highlight the urgent need for robust surveillance systems, judicious antibiotic use, and improved hygiene practices to mitigate the impact of AMR on public health.
Collapse
Affiliation(s)
- Rajindra Napit
- Center for Molecular Dynamics Nepal (CMDN), Kathmandu, Nepal
- Central Department of Biotechnology, Tribhuvan University, Kathmandu, Nepal
- School of Medicine, Deakin University, Victoria, Australia
| | - Anupama Gurung
- Center for Molecular Dynamics Nepal (CMDN), Kathmandu, Nepal
| | - Ajit Poudel
- Center for Molecular Dynamics Nepal (CMDN), Kathmandu, Nepal
| | - Ashok Chaudhary
- Center for Molecular Dynamics Nepal (CMDN), Kathmandu, Nepal
| | | | | | - Samita Raut
- Center for Molecular Dynamics Nepal (CMDN), Kathmandu, Nepal
| | | | - Jyotsna Joshi
- Center for Molecular Dynamics Nepal (CMDN), Kathmandu, Nepal
| | - Mathilde Poyet
- Dept. of Biological Engineering, Massachusetts Institute of Technology, Cambridge, USA
| | - Mathieu Groussin
- Dept. of Biological Engineering, Massachusetts Institute of Technology, Cambridge, USA
| | | | - Dibesh B Karmacharya
- Center for Molecular Dynamics Nepal (CMDN), Kathmandu, Nepal.
- School of the Environment, University of Queensland, Brisbane, Australia.
| |
Collapse
|
3
|
Plummer P, Fajt VR. Biosecurity Practices to Enhance Responsible Antimicrobial Use and Reduce the Burden of Antimicrobial Resistance. Vet Clin North Am Food Anim Pract 2025; 41:25-37. [PMID: 39550313 DOI: 10.1016/j.cvfa.2024.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2024] Open
Abstract
The article shows the case for using biosecurity measures to mitigate antimicrobial resistance (AMR) in beef and dairy production through actions of veterinarians and animal caretakers. The impact of biosecurity on the prevention of bacterial infections is discussed, with the goal being to reduce the need for antimicrobial drugs. This is expected to reduce the selection for AMR in pathogens and commensal bacterial organisms in beef and dairy animals. The potential impact of biosecurity on the prevention of dissemination of antimicrobial resistant bacteria and AMR genes in the environment is also described.
Collapse
Affiliation(s)
- Paul Plummer
- College of Veterinary Medicine, University of Tennessee, A102 Veterinary Medical Center, 2407 River Drive, Knoxville, TN 37996-4503, USA
| | - Virginia R Fajt
- College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4466 TAMU, College Station, TX 77843-4466, USA.
| |
Collapse
|
4
|
Ke X, Smith VA, Mshana SE, Asiimwe B, Neema S, Kiiru J, Mushi MF, Mmbaga BT, Mwanga JR, Kibiki G, Stelling J, Gillespie SH, Green DL, Benvari S, Sabiiti W, Kesby M, Lynch AG, Sandeman A, Sloan DJ, Holden MT, Keenan K. Modelling Interventions to Combat Antibacterial Resistance in East Africa Using Causal Bayesian Networks. RESEARCH SQUARE 2025:rs.3.rs-5944839. [PMID: 39975933 PMCID: PMC11838765 DOI: 10.21203/rs.3.rs-5944839/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/21/2025]
Abstract
Antibacterial resistance (ABR) poses significant challenges to combating infections worldwide. ABR drivers are interconnected, complicating identification of intervention points. Researchers need a systems-based perspective that considers interrelated drivers collectively. We focus on urinary tract infections (UTIs), which are increasingly impacted by emergence of multi-drug resistant (MDR) bacteria. We analysed 2,007 adult outpatients with UTIs in Kenya, Tanzania, and Uganda in 2019-2020. We applied structure learning in Bayesian networks, a graphical probabilistic model, alongside expert knowledge to construct a causal diagram of drivers of prevalence of MDR UTI. MDR prevalence was influenced more by demographic, socioeconomic and environmental conditions than recent antibiotic use. We conducted hypothetical interventions to estimate drivers' causal effects, revealing that improving education access, providing protected drinking water and flush toilets, and reducing overcrowding would decrease MDR prevalence. A systems-based approach identified underlying causal patterns contributing to prevalence of MDR, and could guide the development of complexity-aware targeted interventions.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Blandina T Mmbaga
- Kilimanjaro Clinical Research Institute; Kilimanjaro Christian Medical Centre
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Doyle C, Wall K, Fanning S, McMahon BJ. Making sense of sentinels: wildlife as the One Health bridge for environmental antimicrobial resistance surveillance. J Appl Microbiol 2025; 136:lxaf017. [PMID: 39805713 DOI: 10.1093/jambio/lxaf017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2024] [Revised: 10/25/2024] [Accepted: 01/12/2025] [Indexed: 01/16/2025]
Abstract
Antimicrobial resistance (AMR), arising from decades of imprudent anthropogenic use of antimicrobials in healthcare and agriculture, is considered one of the greatest One Health crises facing healthcare globally. Antimicrobial pollutants released from human-associated sources are intensifying resistance evolution in the environment. Due to various ecological factors, wildlife interact with these polluted ecosystems, acquiring resistant bacteria and genes. Although wildlife are recognized reservoirs and disseminators of AMR in the environment, current AMR surveillance systems still primarily focus on clinical and agricultural settings, neglecting this environmental dimension. Wildlife can serve as valuable sentinels of AMR in the environment, reflecting ecosystem health, and the effectiveness of mitigation strategies. This review explores knowledge gaps surrounding the ecological factors influencing AMR acquisition and dissemination in wildlife, and highlights limitations in current surveillance systems and policy instruments that do not sufficiently address the environmental component of AMR. We discuss the underutilized opportunity of using wildlife as sentinel species in a holistic, One Health-centred AMR surveillance system. By better integrating wildlife into systematic AMR surveillance and policy, and leveraging advances in high-throughput technologies, we can track and predict resistance evolution, assess the ecological impacts, and better understand the complex dynamics of environmental transmission of AMR across ecosystems.
Collapse
Affiliation(s)
- Caoimhe Doyle
- UCD School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland
- UCD-Centre for Food Safety, School of Public Health, Physiotherapy and Sports Science, University College Dublin, Belfield, Dublin 4, Ireland
| | - Katie Wall
- UCD-Centre for Food Safety, School of Public Health, Physiotherapy and Sports Science, University College Dublin, Belfield, Dublin 4, Ireland
| | - Séamus Fanning
- UCD-Centre for Food Safety, School of Public Health, Physiotherapy and Sports Science, University College Dublin, Belfield, Dublin 4, Ireland
| | - Barry J McMahon
- UCD School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland
| |
Collapse
|
6
|
Bartsch S, Scholz KJ, Al-Ahmad A, Cieplik F. Effects of Antimicrobial Agents Used for Dental Treatments: Impacts on the Human Oral Ecosystem and the Resistome. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2025; 1472:261-275. [PMID: 40111697 DOI: 10.1007/978-3-031-79146-8_16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/22/2025]
Abstract
Antimicrobial resistance (AMR) is a major public health concern, especially with regard to bacterial resistance to antibiotics. Dentists are responsible for approximately 10% of all antibiotic prescriptions. In addition, there seems to be a lack of awareness of potential resistance toward antiseptics and biocides such as chlorhexidine digluconate (CHX) or cetylpyridinium chloride (CPC), which are commonly used in dental practice but also included in over-the-counter products. In comparison to the gut microbiome, only a small number of studies have investigated the impact of antibiotics on the oral microbiome. Amoxicillin is a commonly prescribed antibiotic in dentistry, often used in combination with metronidazole. Several studies have addressed its impact on the oral microbiome. Similarly, the effects of ciprofloxacin, clindamycin, cephazolin, and benzylpenicillin have also been examined in various studies. However, due to variations in study designs, it is difficult to compare the effects of antibiotics on the oral microbiota, and conclusions can only be drawn at the phyla level. In contrast, studies on CPC and CHX have also focused on the genus level. The oral resistome mainly contains genes involved in resistance to macrolides, MLSB (macrolide, lincosamide, and streptogramin B), lincosamide and streptogramin A, fluoroquinolone, tetracycline, or penicillin. The oral cavity therefore serves as a reservoir for antibiotic resistance genes (ARGs), which are of crucial importance both for inflammations in the oral cavity and for the treatment of the entire human organism. Therefore, dentists must weigh up the benefits and risks of using antibiotics very carefully.
Collapse
Affiliation(s)
- Sibylle Bartsch
- Center for Dental Medicine, Department of Operative Dentistry and Periodontology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
| | - Konstantin J Scholz
- Center for Dental Medicine, Department of Operative Dentistry and Periodontology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
| | - Ali Al-Ahmad
- Center for Dental Medicine, Department of Operative Dentistry and Periodontology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
| | - Fabian Cieplik
- Center for Dental Medicine, Department of Operative Dentistry and Periodontology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
| |
Collapse
|
7
|
Furlan JPR, Sellera FP, Lincopan N, Debone D, Miraglia SGEK, Tavella RA. Catastrophic floods and antimicrobial resistance: Interconnected threats with wide-ranging impacts. One Health 2024; 19:100891. [PMID: 39310088 PMCID: PMC11415860 DOI: 10.1016/j.onehlt.2024.100891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2024] [Revised: 09/06/2024] [Accepted: 09/07/2024] [Indexed: 09/25/2024] Open
Abstract
•Climate change and AMR combined worsen vulnerabilities, accelerating AMR spread.•Floods can spread AMR-related pathogens, impacting health, agriculture, and ecosystems.•Integrated strategies are needed to address climate change and AMR, enhancing sanitation.
Collapse
Affiliation(s)
- João Pedro Rueda Furlan
- Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil
- ARIES, Antimicrobial Resistance Institute of São Paulo, São Paulo, Brazil
| | - Fábio Parra Sellera
- Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil
- School of Veterinary Medicine, Metropolitan University of Santos, Santos, Brazil
| | - Nilton Lincopan
- ARIES, Antimicrobial Resistance Institute of São Paulo, São Paulo, Brazil
- Department of Microbiology, Instituto de Ciências Biomédicas, University of São Paulo, São Paulo, Brazil
- Department of Clinical Analysis, Faculty of Pharmacy, University of São Paulo, São Paulo, Brazil
| | - Daniela Debone
- ARIES, Antimicrobial Resistance Institute of São Paulo, São Paulo, Brazil
- Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, Brazil
| | - Simone Georges El Khouri Miraglia
- ARIES, Antimicrobial Resistance Institute of São Paulo, São Paulo, Brazil
- Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, Brazil
| | - Ronan Adler Tavella
- ARIES, Antimicrobial Resistance Institute of São Paulo, São Paulo, Brazil
- Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, Brazil
| |
Collapse
|
8
|
Yun IJ, Park HJ, Chae J, Kim YC, Kim B, Choi JY. Reply: Response to Nationwide Analysis of Antimicrobial Prescription in Korean Hospitals between 2018 and 2021: The 2023 KONAS Report. Infect Chemother 2024; 56:557-558. [PMID: 39762932 PMCID: PMC11704867 DOI: 10.3947/ic.2024.0109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2024] [Accepted: 09/24/2024] [Indexed: 01/11/2025] Open
Affiliation(s)
- I Ji Yun
- Department of pharmacy, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
| | - Hyo Jung Park
- Department of Pharmaceutical Services, Samsung Medical Center, Seoul, Korea
- School of Pharmacy, Sungkyunkwan University, Suwon, Korea
| | - Jungmi Chae
- Health Insurance Review and Assessment (HIRA) Research Institute, Wonju, Korea
| | - Yong Chan Kim
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
| | - Bongyoung Kim
- Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
| | - Jun Yong Choi
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
| |
Collapse
|
9
|
Desvars-Larrive A, Burger P, Khol JL, Posautz A, Schernhammer E, Kutalek R, Puspitarani GA, Schlippe Justicia L, Springer DN, Ernst D, Sohm C, Pontel de Almeida A, Schobesberger H, Knauf S, Walzer C. Launching Austria's One Health network: paving the way for transdisciplinary collaborations. ONE HEALTH OUTLOOK 2024; 6:23. [PMID: 39465432 PMCID: PMC11514587 DOI: 10.1186/s42522-024-00116-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/24/2024] [Accepted: 08/29/2024] [Indexed: 10/29/2024]
Abstract
In the post-COVID-19 era, stakeholders, including policymakers, funders, and the public, are increasingly seeking for a cross-sectoral systems-based approach to health risks extending beyond conventional measures. Anchored on three health pillars -human, animal, and environmental- One Health offers a promising framework to effectively address this demand. While some nations have already implemented national One Health strategic plans, European countries, in general, are lagging behind the global agenda. On 22 February 2024, an initiative was launched in Austria toward addressing this gap, bringing together multiple sectors and disciplines, marking the initial step in creating a national One Health network. The workshop emphasized the importance of enhancing One Health education and addressed key topics, such as incorporating the environmental pillar of One Health as well as socio-economic and cultural drivers to further our understanding of outbreaks, and establishing trusted communication channels, including data sharing, between disciplines and sectors. Identified challenges encompassed the need for more funding of transdisciplinary research. Opportunities for advancement include initiating local One Health projects and showcasing their positive impacts. Moving forward, efforts will focus on establishing a mature and globally connected One Health framework in Austria and supporting the integration of One Health aspects into education curricula, research programs, and policies.
Collapse
Affiliation(s)
- Amélie Desvars-Larrive
- Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria.
- Complexity Science Hub, Josefstaedter Strasse, Vienna, 1080, Austria.
| | - Pamela Burger
- Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Savoyenstraße 1, Vienna, 1160, Austria
| | - Johannes Lorenz Khol
- Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria
| | - Annika Posautz
- Vice-Rectorate for Study Affairs and Clinical Veterinary Medicine, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria
| | - Eva Schernhammer
- Department of Epidemiology, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria
| | - Ruth Kutalek
- Department of Social and Preventive Medicine, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria
| | - Gavrila Amadea Puspitarani
- Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria
- Complexity Science Hub, Josefstaedter Strasse, Vienna, 1080, Austria
| | - Lia Schlippe Justicia
- Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Savoyenstraße 1, Vienna, 1160, Austria
| | - David Niklas Springer
- Center for Virology, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria
| | - Damien Ernst
- Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria
| | - Cynthia Sohm
- Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria
| | - Anna Pontel de Almeida
- Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria
- Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria
| | - Hermann Schobesberger
- Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Austria
| | - Sascha Knauf
- Institute of International Animal Health/One Health, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, Greifswald - Insel Riems, 17493, Germany
- International Animal Health, Faculty of Veterinary Medicine, Justus Liebig University, Frankfurter Strasse 106, Giessen, 35392, Germany
| | - Chris Walzer
- Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Savoyenstraße 1, Vienna, 1160, Austria
- Wildlife Conservation Society, 2300 Southern Boulevard Bronx, New York, 10460, NY, USA
| |
Collapse
|
10
|
Banerji A, Brinkman NE, Davis B, Franklin A, Jahne M, Keely SP. Food Webs and Feedbacks: The Untold Ecological Relevance of Antimicrobial Resistance as Seen in Harmful Algal Blooms. Microorganisms 2024; 12:2121. [PMID: 39597512 PMCID: PMC11596618 DOI: 10.3390/microorganisms12112121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2024] [Revised: 10/16/2024] [Accepted: 10/17/2024] [Indexed: 11/29/2024] Open
Abstract
Antimicrobial resistance (AMR) has long been framed as an epidemiological and public health concern. Its impacts on the environment are unclear. Yet, the basis for AMR is altered cell physiology. Just as this affects how microbes interact with antimicrobials, it can also affect how they interact with their own species, other species, and their non-living environment. Moreover, if the microbes are globally notorious for causing landscape-level environmental issues, then these effects could alter biodiversity and ecosystem function on a grand scale. To investigate these possibilities, we compiled peer-reviewed literature from the past 20 years regarding AMR in toxic freshwater cyanobacterial harmful algal blooms (HABs). We examined it for evidence of AMR affecting HAB frequency, severity, or persistence. Although no study within our scope was explicitly designed to address the question, multiple studies reported AMR-associated changes in HAB-forming cyanobacteria (and co-occurring microbes) that pertained directly to HAB timing, toxicity, and phase, as well as to the dynamics of HAB-afflicted aquatic food webs. These findings highlight the potential for AMR to have far-reaching environmental impacts (including the loss of biodiversity and ecosystem function) and bring into focus the importance of confronting complex interrelated issues such as AMR and HABs in concert, with interdisciplinary tools and perspectives.
Collapse
Affiliation(s)
- Aabir Banerji
- US Environmental Protection Agency, Office of Research and Development, Duluth, MN 55804, USA
| | - Nichole E. Brinkman
- US Environmental Protection Agency, Office of Research and Development, Cincinnati, OH 45268, USA; (N.E.B.); (B.D.); (M.J.)
| | - Benjamin Davis
- US Environmental Protection Agency, Office of Research and Development, Cincinnati, OH 45268, USA; (N.E.B.); (B.D.); (M.J.)
| | - Alison Franklin
- US Environmental Protection Agency, Office of Research and Development, Cincinnati, OH 45268, USA; (N.E.B.); (B.D.); (M.J.)
| | - Michael Jahne
- US Environmental Protection Agency, Office of Research and Development, Cincinnati, OH 45268, USA; (N.E.B.); (B.D.); (M.J.)
| | - Scott P. Keely
- US Environmental Protection Agency, Office of Research and Development, Cincinnati, OH 45268, USA; (N.E.B.); (B.D.); (M.J.)
| |
Collapse
|
11
|
Scarpa F, Casu M. Genomics and Bioinformatics in One Health: Transdisciplinary Approaches for Health Promotion and Disease Prevention. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2024; 21:1337. [PMID: 39457310 PMCID: PMC11507412 DOI: 10.3390/ijerph21101337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Revised: 10/02/2024] [Accepted: 10/07/2024] [Indexed: 10/28/2024]
Abstract
The One Health concept underscores the interconnectedness of human, animal, and environmental health, necessitating an integrated, transdisciplinary approach to tackle contemporary health challenges. This perspective paper explores the pivotal role of genomics and bioinformatics in advancing One Health initiatives. By leveraging genomic technologies and bioinformatics tools, researchers can decode complex biological data, enabling comprehensive insights into pathogen evolution, transmission dynamics, and host-pathogen interactions across species and environments (or ecosystems). These insights are crucial for predicting and mitigating zoonotic disease outbreaks, understanding antimicrobial resistance patterns, and developing targeted interventions for health promotion and disease prevention. Furthermore, integrating genomic data with environmental and epidemiological information enhances the precision of public health responses. Here we discuss case studies demonstrating successful applications of genomics and bioinformatics in One Health contexts, such as including data integration, standardization, and ethical considerations in genomic research. By fostering collaboration among geneticists, bioinformaticians, epidemiologists, zoologists, and data scientists, the One Health approach can harness the full potential of genomics and bioinformatics to safeguard global health. This perspective underscores the necessity of continued investment in interdisciplinary education, research infrastructure, and policy frameworks to effectively employ these technologies in the service of a healthier planet.
Collapse
Affiliation(s)
- Fabio Scarpa
- Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
| | - Marco Casu
- Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy
| |
Collapse
|
12
|
Singh A, Rani PS, Bandsode V, Nyambero M, Qumar S, Ahmed N. Drivers of virulence and antimicrobial resistance in Gram-negative bacteria in different settings: A genomic perspective. INFECTION, GENETICS AND EVOLUTION : JOURNAL OF MOLECULAR EPIDEMIOLOGY AND EVOLUTIONARY GENETICS IN INFECTIOUS DISEASES 2024; 124:105666. [PMID: 39242067 DOI: 10.1016/j.meegid.2024.105666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/07/2024] [Revised: 08/13/2024] [Accepted: 09/02/2024] [Indexed: 09/09/2024]
Abstract
The human gut presents a complex ecosystem harboring trillions of microorganisms living in close association with each other and the host body. Any perturbation or imbalance of the normal gut microbiota may prove detrimental to human health. Enteric infections and treatment with antibiotics pose major threats to gut microbiota health. Recent genomics-driven research has provided insights into the transmission and evolutionary dynamics of major enteric pathogens such as Escherichia coli, Klebsiella pneumoniae, Vibrio cholerae, Helicobacter pylori and Salmonella spp. Studies entailing the identification of various dominant lineages of some of these organisms based on artificial intelligence and machine learning point to the possibility of a system for prediction of antimicrobial resistance (AMR) as some lineages have a higher propensity to acquire virulence and fitness advantages. This is pertinent in the light of emerging AMR being one of the immediate threats posed by pathogenic bacteria in the form of a multi-layered fitness manifesting as phenotypic drug resistance at the level of clinics and field settings. To develop a holistic or systems-level understanding of such devastating traits, present methodologies need to be advanced with the high throughput techniques integrating community and ecosystem/niche level data across different omics platforms. The next major challenge for public health epidemiologists is understanding the interactions and functioning of these pathogens at the community level, both in the gut and outside. This would provide new insights into the dimensions of enteric bacteria in different environments and niches and would have a plausible impact on infection control strategies in terms of tackling AMR. Hence, the aim of this review is to discuss virulence and AMR in Gram-negative pathogens, the spillover of AMR and methodological advancements aimed at addressing it through a unified One Health framework applicable to the farms, the environment, different clinical settings and the human gut.
Collapse
Affiliation(s)
- Anuradha Singh
- Pathogen Biology Laboratory, Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, Telangana, India
| | - Pittu Sandhya Rani
- Pathogen Biology Laboratory, Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, Telangana, India
| | - Viraj Bandsode
- Pathogen Biology Laboratory, Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, Telangana, India
| | - Mahanga Nyambero
- Pathogen Biology Laboratory, Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, Telangana, India
| | - Shamsul Qumar
- Pathogen Biology Laboratory, Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, Telangana, India
| | - Niyaz Ahmed
- Pathogen Biology Laboratory, Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, Telangana, India.
| |
Collapse
|
13
|
Baldi A, Braat S, Imrul Hasan M, Bennett C, Barrios M, Jones N, Moir-Meyer G, Abdul Azeez I, Wilcox S, Saiful Alam Bhuiyan M, Ataide R, Clucas D, Harrison LC, Arifeen SE, Bowden R, Biggs BA, Jex A, Pasricha SR. Community use of oral antibiotics transiently reprofiles the intestinal microbiome in young Bangladeshi children. Nat Commun 2024; 15:6980. [PMID: 39143045 PMCID: PMC11324872 DOI: 10.1038/s41467-024-51326-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Accepted: 08/05/2024] [Indexed: 08/16/2024] Open
Abstract
Antibiotics may alter the gut microbiome, and this is one of the mechanisms by which antimicrobial resistance may be promoted. Suboptimal antimicrobial stewardship in Asia has been linked to antimicrobial resistance. We aim to examine the relationship between oral antibiotic use and composition and antimicrobial resistance in the gut microbiome in 1093 Bangladeshi infants. We leverage a trial of 8-month-old infants in rural Bangladesh: 61% of children were cumulatively exposed to antibiotics (most commonly cephalosporins and macrolides) over the 12-month study period, including 47% in the first 3 months of the study, usually for fever or respiratory infection. 16S rRNA amplicon sequencing in 11-month-old infants reveals that alpha diversity of the intestinal microbiome is reduced in children who received antibiotics within the previous 7 days; these samples also exhibit enrichment for Enterococcus and Escherichia/Shigella genera. No effect is seen in children who received antibiotics earlier. Using shotgun metagenomics, overall abundance of antimicrobial resistance genes declines over time. Enrichment for an Enterococcus-related antimicrobial resistance gene is observed in children receiving antibiotics within the previous 7 days, but not earlier. Presence of antimicrobial resistance genes is correlated to microbiome composition. In Bangladeshi children, community use of antibiotics transiently reprofiles the gut microbiome.
Collapse
Affiliation(s)
- Andrew Baldi
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.
| | - Sabine Braat
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Centre for Epidemiology and Biostatistics, University of Melbourne School of Population and Global Health, Carlton, VIC, Australia
- Department of Infectious Diseases at the Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia
| | - Mohammed Imrul Hasan
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia
- International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b), Dhaka, Bangladesh
| | - Cavan Bennett
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia
| | - Marilou Barrios
- Advanced Technology and Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
| | - Naomi Jones
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
| | - Gemma Moir-Meyer
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia
| | - Imadh Abdul Azeez
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia
| | - Stephen Wilcox
- Advanced Technology and Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
| | | | - Ricardo Ataide
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Department of Infectious Diseases at the Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia
| | - Danielle Clucas
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia
- Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia
| | - Leonard C Harrison
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia
| | - Shams El Arifeen
- International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b), Dhaka, Bangladesh
| | - Rory Bowden
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia
- Advanced Technology and Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
| | - Beverley-Ann Biggs
- Department of Infectious Diseases at the Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia
- Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, VIC, Australia
| | - Aaron Jex
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia
- Faculty of Science, University of Melbourne, Melbourne, VIC, Australia
| | - Sant-Rayn Pasricha
- Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
- Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.
- Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
- Clinical Haematology at The Royal Melbourne Hospital and the Peter MacCallum Cancer Centre, Parkville, VIC, Australia.
| |
Collapse
|
14
|
Sadreghaemy M, Gamba MA, Bloem LT, Egberts TCG. Leftover of Amoxicillin Suspension After Use by Children in the Netherlands. Pharmacoepidemiol Drug Saf 2024; 33:e5868. [PMID: 39092463 DOI: 10.1002/pds.5868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Revised: 06/18/2024] [Accepted: 06/24/2024] [Indexed: 08/04/2024]
Abstract
PURPOSE In clinical practice, a discrepancy may exist between the prescribed amount of a drug and the commercially available pack sizes in the pharmacy, potentially contributing to drug waste. This study aimed-as an example of this phenomena-to quantify leftover of amoxicillin suspension prescribed to children, due to discrepancies between physician-prescribed and pharmacy-dispensed amounts. METHODS We performed a retrospective cohort study including amoxicillin suspension dispensations for patients aged 0-12 years between 2017 and 2019 utilizing the Dutch PHARMO database. Leftover amount of amoxicillin was estimated by assessing the discrepancy between the prescribed and dispensed amounts. Extrapolated amoxicillin weight and economic spillage estimates for the Netherlands were determined. The impact of two theoretical interventions on leftover amount was assessed: (1) introducing vials with half the volume of the current 100 and 30 mL vials and (2) a combination of the first intervention with a maximum of 10% round-down by the dispensing pharmacy of the prescribed dose. RESULTS We included 79 512 amoxicillin suspension dispensations for 62 252 patients. The mean leftover amount of amoxicillin suspension per dispensing was 27%. The yearly amount of amoxicillin leftover was 49.8 kg in the study cohort, equivalent to yearly 633 kg and €621 000 when extrapolated to the Netherlands. Employing the first theoretical intervention reduced the mean leftover per dispensing to 20%, reducing the yearly leftover to 31.6 kg amoxicillin in the study cohort, and to 400 kg and €400 000 extrapolated. The second theoretical intervention further reduced leftover to 17%, reducing the yearly leftover to 24.3 kg amoxicillin in the study cohort, and to 300 kg and €300 000 extrapolated. CONCLUSION Approximately a quarter of amoxicillin suspension remains as leftover per dispensing. Applying different theoretical intervention shows the potential for a significant reduction of amoxicillin leftover.
Collapse
Affiliation(s)
- Milad Sadreghaemy
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
| | - Magdalena A Gamba
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
| | - Lourens T Bloem
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
| | - Toine C G Egberts
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
- Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands
| |
Collapse
|
15
|
Abbas A, Barkhouse A, Hackenberger D, Wright GD. Antibiotic resistance: A key microbial survival mechanism that threatens public health. Cell Host Microbe 2024; 32:837-851. [PMID: 38870900 DOI: 10.1016/j.chom.2024.05.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2024] [Revised: 05/13/2024] [Accepted: 05/17/2024] [Indexed: 06/15/2024]
Abstract
Antibiotic resistance (AMR) is a global public health threat, challenging the effectiveness of antibiotics in combating bacterial infections. AMR also represents one of the most crucial survival traits evolved by bacteria. Antibiotics emerged hundreds of millions of years ago as advantageous secondary metabolites produced by microbes. Consequently, AMR is equally ancient and hardwired into the genetic fabric of bacteria. Human use of antibiotics for disease treatment has created selection pressure that spurs the evolution of new resistance mechanisms and the mobilization of existing ones through bacterial populations in the environment, animals, and humans. This integrated web of resistance elements is genetically complex and mechanistically diverse. Addressing this mode of bacterial survival requires innovation and investment to ensure continued use of antibiotics in the future. Strategies ranging from developing new therapies to applying artificial intelligence in monitoring AMR and discovering new drugs are being applied to manage the growing AMR crisis.
Collapse
Affiliation(s)
- Amna Abbas
- David Braley Center for Antibiotic Discovery, Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada
| | - Alexandra Barkhouse
- David Braley Center for Antibiotic Discovery, Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada
| | - Dirk Hackenberger
- David Braley Center for Antibiotic Discovery, Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada
| | - Gerard D Wright
- David Braley Center for Antibiotic Discovery, Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
| |
Collapse
|
16
|
Seguin-Devaux C, Mestrovic T, Arts JJ, Sen Karaman D, Nativi C, Reichmann D, Sahariah P, Smani Y, Rijo P, Mori M. Solving the antibacterial resistance in Europe: The multipronged approach of the COST Action CA21145 EURESTOP. Drug Resist Updat 2024; 74:101069. [PMID: 38458099 DOI: 10.1016/j.drup.2024.101069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Revised: 02/15/2024] [Accepted: 02/15/2024] [Indexed: 03/10/2024]
Affiliation(s)
- Carole Seguin-Devaux
- Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg.
| | - Tomislav Mestrovic
- Department of Nursing, University Centre Varaždin, University North, Varazdin 42 000, Croatia; Institute for Health Metrics and Evaluation and the Department of Health Metrics Sciences, University of Washington, Seattle, WA 98195, USA
| | - Jacobus J Arts
- Laboratory for Experimental Orthopaedics, Department of Orthopaedic Surgery, Maastricht University Medical Center, the Netherlands; Department Orthopaedic Biomechanics, Faculty Biomedical Engineering, Eindhoven University of Technology TU/e, the Netherlands
| | - Didem Sen Karaman
- İzmir Katip Çelebi University, department of Biomedical Engineering, Turkey
| | - Cristina Nativi
- University of Florence, Department of Chemistry "Ugo Schiff", Italy
| | - Dana Reichmann
- Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Israel; The Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Israel
| | - Priyanka Sahariah
- Department of Life and Environmental Sciences, Biomedical Centre, University of Iceland, Reykjavik 101, Iceland
| | - Younes Smani
- Department of Molecular Biology and Biochemical Engineering, Andalusian Center of Developmental Biology, CSIC, University of Pablo de Olavide, Seville, Spain; Andalusian Center of Developmental Biology, University of Pablo de Olavide University, CSIC, Seville, Spain
| | - Patricia Rijo
- CBIOS (Research Center for Biosciences and Health Technologies), Universidade Lusófona, Lisbon, Portugal
| | - Mattia Mori
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Italy
| |
Collapse
|